TMCx company BetterConsult is premiering its software in Houston as its entrance to the U.S. market. Getty images

Long hours, high-stress situations and overwhelming college debt contribute to burnout among physicians. But so does something you might not have pondered: record keeping.

The clerical burden triggered by electronic medical records, or EHRs, "has become a leading cause of physician burnout," according to a 2017 article in the Canadian Medical Association Journal. That declaration is backed up by a 2014 survey of 6,375 physicians in the U.S.

Technology from a startup called BetterConsult Inc., which recently planted its roots in Houston, aims to help diminish clerical burdens and physician burnout. BetterConsult is one of the latest entrants in the $31.5 billion global EHR market.

Through an online questionnaire, BetterConsult's software captures a patient's symptoms, medication, and other clinical information before an office visit. It then translates the data into concise medical notes available for a doctor to review.

BetterConsult says its technology can:

  • Decrease administrative tasks.
  • Enable doctors to see more patients.
  • Offer better insight into a patient's condition.
  • Improve patient outcomes.

Chris Barakat, senior vice president of BetterConsult, says Houston is the first U.S. market for the startup's offering. BetterConsult already is up and running in Australia, where parent company HealthShare Pty Ltd., a provider of healthcare technology, is based.

Barakat seeks to sign up at least 5,000 doctors — primary care physicians and medical specialists — in the Houston area by January 2023, which he says would result in about 400,000 patient e-consultations per week.

"BetterConsult has a vast database of symptoms and concerns available for patients to select which provides additional actionable information to the physician," Barakat wrote in a post on Medium.com. "In addition, the application can be used to support the continuum of care by updating the patient information for future visits. The solution has potential applications to provide value in emerging areas including telehealth, mental health, and population health."

Telehealth alone holds massive potential. A recent report from Global Market Insights forecasts the worldwide telehealth market will reach $130.5 billion by 2025, up from the current $38.3 billion.

"Telehealth is part of a larger digital transformation in health care. The electronic health record, omnipresent mobile devices, and faster internet connections have provided new ways for patients and providers to interact," the American Hospital Association says.

At this point, Barakat is BetterConsult's sole employee in the Houston office, but the company plans to add an untold number of sales, marketing, and support professionals. The startup graduated in June from the TMCx business accelerator at the Texas Medical Center Innovation Institute.

BetterConsult's technology is slowly being rolled out in the Houston area. Barakat says the BetterConsult software will be piloted at two major healthcare systems in Texas.

Dr. Rajat Bhatt has installed BetterConsult's software at his three rheumatology clinics in the Houston area. Bhatt says the technology has cut documentation work by 40 percent. In addition, he says, it has decreased diagnosis errors, thanks to taking into account a patient's full medical history rather than just a current condition.

"The time I am saving is allowing me to increase the number of patients I see per day, helping to reduce the extensive wait times for Texans to see a rheumatologist," Bhatt says. "Because of the volume of patients I can now see, it has made my business much more economical. I can now see new patients within a week."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hypersonic engine company lands investment from deep-tech firm

super speed

Hypersonic engine technology company Venus Aerospace announced an investment for an undisclosed amount from deep-tech investment firm America's Frontier Fund (AFF).

Venus plans to use the funds to advance its VDR2 engine has the potential to support a commercial flight from Los Angeles to Tokyo in under two hours, according to a statement.

"AFF's investment in Venus Aerospace underscores our focus on supporting American companies that are revolutionizing industries of the future," Jordan Blashek, Co-Founder and Managing Partner of AFF, said in a news release. "With recent hypersonic advancements from China and Russia, safeguarding American innovation and securing our industrial base has never been more urgent. Venus Aerospace is poised to redefine hypersonic flight and ensure America's continued leadership in aerospace innovation."

Venus plans to integrate components of its RDRE engine into the advanced VDR2 engine, increasing efficiency with air-augmentation technology capable of 2,000 pounds of thrust. This will allow the VDR2 engine to operate at wider ranges of speeds and altitudes. The company plans to ground-test the VDR2 in 2025.

Venus also plans to make history this year by conducting the first atmospheric flight of its RDRE engine, which has applications in the space and defense industries.

"AFF's commitment to pioneering technological advancements aligns seamlessly with our mission to enhance American competitiveness in hypersonics,” Sassie Duggleby, CEO and co-Founder of Venus Aerospace, added in the news release. “Their deep-tech expertise and proven track record in scaling innovative companies will be invaluable as we work to achieve our goals."

Venus Aerospace believes these innovations can “strengthen U.S. leadership in aerospace, defense, and energy innovation."

Venus also aims to use its engine technology to power the Stargazer M4, the world's first Mach 4 reusable commercial aircraft and a prime example of advanced propulsion systems.

The company launched in 2020 and has gained $78.3 million in total investments, according to Pitchbook data.

Houston manufacturer names location of its $193.7 million facility

coming soon

Houston-based manufacturer of high-temperature superconducting wires MetOx International Inc. will build a major production facility in Chatham County, North Carolina, which is expected to create 333 jobs, and invest $193.7 million in the state.

MetOx is a leader in High Temperature Superconducting technology (HTS), which is an advanced power delivery technology that is capable of transmitting extremely high power at low voltage with zero heat generation or energy loss. The technology is assisting in the energy sectors like power transmission, distribution, and grid expansion.

“Establishing our new large-scale manufacturing facility in Chatham County is a pivotal step toward securing a reliable, domestic supply of HTS wire for the development of critical infrastructure in the United States,” Bud Vos, CEO of MetOx, says in a news release. “This facility will not only deliver transformative energy technologies that strengthen our grid and reduce carbon emissions but also create high-paying manufacturing jobs in a community eager to lead in innovation. We are proud to partner with North Carolina to drive forward a resilient energy future built on cutting-edge science and strong local collaboration.”

The new facility is funded in part by an $80 million investment from the United States Department of Energy, which the company announced in October. In September, the company closed $25 million in a series B extension round.

In late 2024, MetOx also announced that it received an undisclosed investment from Hawaii-based Elemental Impact, which is a leading climate-focused investment platform. As a national implementation partner for the EPA's $27 billion Greenhouse Gas Reduction Fund, Elemental Impact has received $100 million to deploy later-stage commercialized technologies according to the company.

The funding is expected to advance the expansion of MetOx’s Houston production line and the deployment of its HTS wire, which can make transmission cables up to ten times more efficient than traditional copper cables and will be used at the North Carolina facility.

“Building domestic manufacturing capacity for critical grid technologies is essential for America’s energy future," Danya Hakeem, vice president of Portfolio at Elemental Impact, says in a news release. “MetOx’s expansion in Houston demonstrates how we can simultaneously advance grid modernization and create quality manufacturing jobs. Their technology represents exactly the kind of innovation needed to unlock the next wave of clean energy deployment.”

The project in North Carolina will be facilitated with a Job Development Investment Grant formally awarded to a new company being created by MetOx. In the 12-year term of the grant, economists in the Department of Commerce estimated the project will grow North Carolina’s economy by $987.8 million.

------

This article originally was published on our sister site, EnergyCapital.

Houston Nobel Prize nominee earns latest award for public health research

Prized Research

Houston vaccine scientist Dr. Peter Hotez can add one more prize to his shelf.

Hotez — dean of the National School of Tropical Medicine and professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, co-director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics — is no stranger to impressive laurels. In 2022, he was even nominated for a Nobel Peace Prize for his low-cost COVID vaccine.

His first big win of 2025 is this year’s Hill Prize, awarded by the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

Hotez and his team were selected to receive $500,000 from Lyda Hill Philanthropies to help fund The Texas Virosphere Project. The endeavor was born to help create a predictive disease atlas relating to climate disasters. Because the climate crisis has ushered in changes to the distribution of diseases, including dengue, chikungunya, Zika, Chagas disease, typhus and tick-borne relapsing fever, it’s important to predict outbreaks before they become a menace.

Rice University researchers are collaborating with Hotez and his team on a project that combines climate science and metagenomics to access 3,000 insect genomes. The goal is to aid health departments in controlling disease and informing policy.

The Hill Prize, which is being awarded to six innovators for the first time, thanks to a $10 million commitment from the philanthropic organization, is intended to back ideas that are high-risk and high-reward. Each of the projects was chosen for its potential real-life impact on some of Texas's — and the world’s — most challenging situations. Hotez’s prize is the first Hill Prize to be given in the realm of public health. The additional winners are:

  • Hill Prize in Medicine: Kenneth M. Hargreaves, D.D.S., Ph.D., The University of Texas Health Science Center at San Antonio
  • Hill Prize in Engineering: Joan Frances Brennecke, Ph.D. (NAE), The University of Texas at Austin
  • Hill Prize in Biological Sciences: David J. Mangelsdorf, Ph.D. (NAM, NAS), UT Southwestern Medical Center
  • Hill Prize in Physical Sciences: James Chelikowsky, Ph.D., The University of Texas at Austin
  • Hill Prize in Technology: Robert De Lorenzo, M.D., EmergenceMed, LLC
Read about other Houston-area researchers recognized by TAMEST here.